TY - JOUR T1 - Differences in the economic valuation and determining factors of informal care over time: the case of blood cancer JO - Gaceta Sanitaria T2 - AU - Ortega-Ortega,Marta AU - Montero-Granados,Roberto AU - Jiménez-Aguilera,Juan de Dios SN - 02139111 M3 - 10.1016/j.gaceta.2017.02.006 DO - 10.1016/j.gaceta.2017.02.006 UR - https://gacetasanitaria.org/en-differences-in-economic-valuation-determining-articulo-S0213911117300948 AB - ObjectiveTo estimate differences in the economic valuation and sociodemographic and clinical factors associated with informal care between phases of the treatment in the case of blood cancer patients. Methods139 haematological cancer patients who underwent a stem cell transplantation completed a longitudinal questionnaire according to 3 phases of the treatment: short-term (pre-transplant), medium-term (1st year post-transplant) and long-term (2nd-6th year post-transplant). Economic value of informal care was estimated using proxy good and opportunity cost methods. Ordered and binary logistic models were performed to identify factors associated with informal care. Results123 patients reported having received informal care. A progressive reduction of the number of hours of care was observed between phases. Monetary value per patient ranged from 1,288 to 3,409; 1,045 to 2,786; and 336 to 854 €/month in the short, medium and long term, respectively. Patients with acute leukaemia and those who received an unrelated allogeneic transplantation were 22% (short-term) and 33.5% (medium-term) more likely to receive more than 8hours/day of care respect to patients diagnosed with lymphoma and autologous transplantation. In the long term, patients with multiple myeloma were more likely to receive more care. Better health status and higher educational level were associated with fewer daily hours of care. ConclusionsInformal care varies greatly between stages of the treatment depending on the clinical and sociodemographic factors. Significant caring time and societal costs are associated with such care in blood cancer patients. ER -